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This paper is concerned with a method to elicit leukemia rapidly and in high 
yield  in  the  rat  and with  the  recognition  of the  disease  in living  animals.  A 
series of pulse-doses  (intravenous  injections)  of large but tolerable  amounts of 
homogenized  7,8,12-trimethylbenz(a)anthracene  was  highly  effective  in 
calling forth mammary cancer and leukemia. In juvenile rats leukemia occurred 
preferentially;  in young adults,  male  and female,  both mammary cancer  and 
leukemia  developed  in  profusion.  Leukemia was  detected  within  1  month  in 
many rats  and within  100 days in all young animals which withstood the toxic 
effects of reiterated  pulse-doses.  Predominantly, leukemia  of a  single sort was 
induced;  it was a  stem-cell leukemia  often associated with  erythroblastosis. 
In developing this  simple  and  reproducible  method  we  considered  the  leu- 
kemogenic potency of several  hydrocarbons and the physiologic status  of the 
recipient  most conducive to the development  of neoplasms. 
Bachmann and Chemerda (1) synthesized 7,12-DMBA and 7,8,12-TMBA. 1 These 
compounds are of exceptional interest: (a) they are the most potent polycyclic hydro- 
carbons in inducing tumors, and (b)  they selectively destroy the middle layer of the 
adrenals  of adult rats  (2, 3).  Schurr (4)  devised a  method to prepare rather concen- 
trated lipid  emulsions of hydrocarbons (0.5-1.0% w/w)  suitable  for intravenous in- 
jections.  The toxicity of a  single  pulse-dose of emulsions  of hydrocarbons has been 
determined. In the rat 7,12-DMBA (LD~0  60 mg/kg) is more toxic (5) than is  7,8,12- 
TMBA (LD~o 125 mg/kg). 
The leukemogenic action of hydrocarbons was discovered by Morton and Mider 
(6) by repeatedly painting the skin of mice with 3-methylcholanthrene. Induction of 
leukemia by intravenous injection of hydrocarbons was first accomplished by Huggins 
and  Sugiyama (7).  Under  stated  conditions multiple  pulse-doses  of an  emulsion  of 
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1 The abbreviations used in  this paper are: DMBA,  dimethylbenz(a)anthracene;  DMSO, 
dimethylsulfoxide; TMBA, trimethylbenz(a)anthracene;  4-, standard deviation of mean. 
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7,12-DMBA  induced  leukemia in every rat,  whereas a  single dose elicited it in 6% 
of the animals; the mean survival time of leukemic animals was  102  4- 22 days. 
Huggins and Sugiyama (7)  found that biopsy of the liver was valuable in the early 
diagnosis of leukemia in living rats. In 100 consecutive cases of leukemia, the liver was 
enlarged  (greater  than  4%  of the body weight)  in  76  rats.  Whenever leukemia  was 
detected in any site, leukemic foci always were found in the liver by hepatic biopsy. 
Several  kinds  of  leukemia  were  elicited  by  7,12-DMBA,  but  the  most  common 
category (80%  of the cases)  was a  diffuse hepatic form of a  stem-cell leukemia often 
associated with erythroblastosis. 
Methods 
The experimental animals were exclusively rats of Long-Evans (L-E) strain (8). Our colony 
has been maintained by breeding at random inter se for more than  10 yr. The animals were 
housed in metal cages in air-conditioned rooms at 25°C 4- 2, fed a commercial ration (Rockland 
Mouse/Rat Diet, Teklad,  Inc.,  Monmouth,  Ill.)  and  given water  ad libitum.  6  days each 
week the animals were weighed.  Every day the vaginal smear of each female was examined 
using a  Pasteur pipette and  saline. Rectal temperature was measured each morning with a 
thermocouple. 
Lipid emulsions containing hydrocarbonso- were prepared (3). Cottonseed oil was emulsified 
in water containing lecithin and a nonionic detergent by the method of Schurr (4) ; the hydro- 
carbon was dissolved in dimethyl sulfoxide  (DMSO)  and  diluted with the Schurr  emulsion 
until the final concentrations (w/v) were: hydrocarbon, 0.5%; DMSO, 5%. A reflux condenser 
was attached to the flask and the mixture was boiled for 1 hr with slow stirring. 
The lipid emulsions were injected in a caudal vein; the first injection is designated day 0. 
Biopsy of the liver was performed under ether anesthesia with aseptic precautions. An incision 
(1 cm) was made in the midline in the epigastrium; the spleen was delivered by gentle traction 
and inspected. The liver was not handled; a wedge 50-100 mg was excised cleanly with scissors 
from the margin; hemostasis was not necessary. Blood was obtained from a vein or by cardiac 
puncture for hematologic studies by conventional methods. 
Most of the experiments were terminated when leukemia was detected or at 100 days. 
RESULTS 
Spontaneous  leukemia  is  rare  in  our  colony of Long-Evans  rats.  It was  de- 
tected  in  one  animal  among  6000+  untreated  rats  maintained  as  a  breeding 
stock until  age 6  months.  This leukemia was of thymus-lymph  node type. 
Leukemogenic  Hydrocarbons.--Six  hydrocarbons  (Table  I)  were  evaluated 
for  leukemogenic  potency.  A  lipid  emulsion  of  each  compound  was  freshly 
prepared  and  a  set  of  pulse-doses,  35  mg/kg,  administered  to  young  rats. 
Control  mates  received intravenous  injections  of  emulsions  devoid  of  hydro- 
carbons. 
The  compounds  were  derivatives  of  12-methylbenz(a)anthracene  and 
possessed two or three methyl substituents.  The compounds were closely related 
to  7,12-DMBA  which  was  tested;  four  of  the  derivatives  had  the  structure 
x, 7,12-TMBA. 
°'We thank:  Paul  E.  Schurr,  The  Upjohn  Co.,  Kalamazoo,  Mich.,  for lipid  emulsions; 
John Pataki, Ben May Laboratory for Cancer Research, The University of Chicago, Chicago, 
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7,12-DMBA  was  the  most  toxic  compound. It  caused  gastric  distension, 
ileitis, and diarrhea on days 1-3. Disturbances of this sort were not observed 
in rats which received the other hydrocarbons or in control rats. 
Two compounds, 7,12-DMBA and 7,8,12-TMBA (Table I), elicited leuke- 
mia  in high  and  equal  yield.  Two  compounds,  6,8,12-TMBA  and  7,9,12- 
TMBA, evoked leukemia in low yield. 
TABLE I 
Leukemia Evoked by Sets of Pulse-Doses of Polycydic Aromatic Hydrocarbons 
Female rats were given five pulse-doses of hydrocarbon, 35 mg/kg; control rats received 
lipid emulsion devoid of hydrocarbon. The injections were given at biweekly intervals  be- 
ginning at age 30 days; the experiment was terminated on day 100. 
Compound  Number of rats 
Rats with leukemia 
Total number  % 
7,12-DMBA  44  35  80 
5,7,12-TMBA  10  0  0 
6,7,12-TMBA  8  0  0 
6,8,12-TMBA  9  2  22 
7,8,12-TMBA  10  8  80 
7,9,12-TMBA  14  1  7 
Control; no hydrocarbon  20  0  0 
TABLE II 
Number of Pulse-Doses of 7,8,12-Trimethylbenz(a)anthracene  Related to Incidence of Leukemia 
Female rats of L-E strain were injected with 1-5 pulse-doses of 7,8,12-TMBA, 35 mg/kg, 
at intervals of 10 days beginning at age 28 days; the experiment was terminated  on day 100. 
Number of pulse-doses  Number of rats 
Rats with leukemia 
Total number  % 
1  10  1  10 
3  23  7  30 
4  22  18  82 
5  20  19  95 
Leukemia was  not observed in rats  injected with 5,7,12-TMBA, 6,7,12- 
TMBA,  or  control lipid emulsion. It  is  remarkable that  substitution of  the 
hydrogen atom at positions 5 or 6 in 7,12-DMBA (but not at position 8) by a 
methyl group eliminated the ability of the molecule to induce leukemia; thus, 
7,12-DMBA  and  7,8,12-TMBA were  strongly leukemogenic,  whereas  5,7, 
12-TMBA and 6,7,12-TMBA were inactive in this regard. 
Preferential  Induction  of Leukemia.--Some  rats  which  received  a  series  of 
pulse-doses of 7,8,12-TMBA were unusually vulnerable and they died early in 
the experiment. At necropsy, pneumonitis or  a  wasting disease was found in 324  tt-YDROCARBON-INDUCED LEUKEMIA 
these animals. Rats of L-E strain are  advantageous because, in comparison to 
other strains, they are rather resistant to pneumonitis? 
The  wasting  disease  caused  by  hydrocarbons  in  rats  is  characterized  by 
cachexia and  shrinkage  of most  of the  tissues  with  an  accompanying anemia 
TABLE III 
Tumors Elicited  by Pulse-Doses  of 7,8,12-Trimethylbenz(a)anthracene  in  Older and  Younger 
Rats 
Rats received four pulse-doses of 7,8,12-TMBA, 35  mg/kg, at biweekly intervals.  The 
injections were started in older rats at age 50 days and in younger groups at age 25 days. 
Older group  Younger groups 
Female  Male  Female 
Original number  18  11  14 
Early death  0  1  2 
Effective number  18  10  12 
Nlammarycancer  18  (100%)  1  (10%)  6  (50%) 
Leukemia  10  (56%)  8  (80%)  10  (83%) 
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Fro.  1.  Curves of body weight of (1)  a group  of 20 rats which received 5 pulse-doses of 
7,8,12-TMBA, 35 mg/kg, beginning at age 25 days and  (2) control mates. The day of detec- 
tion of leukemia in a member of the injected group is denoted by -~. 
and leukopenia; liver is small and spleen is tiny, whereas the adrenals are big. 
Rats with leukemia also lose weight and develop anemia,  but in the leukemic 
rats the liver is somewhat or greatly enlarged and there is leukocytosis. 
3 Rats of Sprague-Dawley strain which received a set of pulse-doses of 7,8,12-TMBA were 
very susceptible to pneumonitis,  but leukemia developed in half of the rats which survived 
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The incidence of leukemia elicited by 7,8,12-TMBA in  L-E rats is directly 
related to the number of pulse-doses  (Table II). In our exoeriments the mini- 
mum number of intravenous injections to cause  a  high yield of leukemia was 
four.  A  very high  incidence  of leukemia  (greater  than  80%  of the  effective 
animals)  was found before  100 days in  10 consecutive series,  each comprising 
20-100 rats. 
18 young adult  rats which had had one or more estrus cycles were injected 
with  four  pulse-doses  of  7,8,12-TMBA,  35  mg/kg,  at,  biweekly  intervals. 
Each  animal  developed mammary cancer  (Table  III) which was detected  on 
TABLE IV 
Anatomical Findings in Male Rats with Leukemia 
Leukemia  was elicited in  12 male rats by pulse-doses of 7,8,12-TMBA; necropsy was 
performed on day 42-78 when leukemia was in advanced stage.  10 controls were untreated 
and sacrificed at age 128 days. 
Leukemia  Control 
g/lO0 g  g/lO0 g 
Liver  8.1  4-* 3.4  3.0  :h 0.2 
(4.5-15)  (2.6-3.4) 
Spleen  0.3  4- 0.1  0.74 
(0.1-0.7)  (0.4-1.0) 
Thymus  0.06  -4- 0.01  0.22 
(0.03-0.09) 
Testis  (1)  0.24  4- 0.01  1.9  4- 0.1 
(0.1-0.3)  (1.8-2.0) 
Lymph nodes  0.01  0.006 
* 4., standard deviation of mean. 
days 42-98 (70 -4-  16 days). Benign mammary tumors appeared in many ani- 
mals  after  day  120;  4  rats  developed  aural  cancers.  Myriads  of  mammary 
cancers emerged in these animals during the first 9 months  requiring repeated 
excision  of sizable  tumors  to preserve life;  in these  rats  three  or more newly 
appearing  mammary tumors were  excised  each month to preserve  life  of the 
animal.  Leukemia was  observed in  10 members  of the group (56 %)  on days 
70-160 (99.5  4- 38 days). 
Groups of male and female weanling rats received four pulse-doses of 7,8,12- 
TMBA, 35 mg/kg (Table III). Leukemia was observed in 80% of each group. 
The incidence of mammary cancer in the juvenile males was 10 %. 
A group of 25 female rats received a series of 5 pulse-doses of 7,8,12-TMBA 
starting  at age 25 days (Fig.  1). There were 5 early deaths which occurred on 326  HYDROCARBON-INDUCED LEUKEMIA 
days 48-69:  wasting  disease,  4;  pneumonitis,  1.  Among  20  effective animals 
the following neoplasms were observed: breast cancer, 3; leukemia,  19;  other 
tumors, 0. Leukemia was detected by hepatic biopsy on days 31-95  (53.1  4- 
15  days). Leukemia was classified: stem cell with or without erythroblastosis 
(Figs.  5,  6),  18 cases; myelogenous,  1. The neoplastic myelogenous cells con- 
tained peroxidase granules. 
The most striking anatomical findings (Table IV) in rats with erythroblastic 
leukemia were found  in  the liver.  In  an advanced stage  the  liver was huge, 
dusky rose-red in  color,  mottled,  slightly  granular,  and  friable.  The  hepatic 
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Fro.  2.  Leukocyte counts in cardiac blood of female rats injected with pulse-doses of 
7,8,12-TMBA,  35 mg/kg, and of uninjected mates. There were 5 rats in each group; mean 
values are given. •  0, injected. © .... O, controls. 
edge was  rounded.  Thymus,  lymph nodes,  spleen,  and  testis  were  much  re- 
duced in size. In advanced cases, clumps of leukemic cells were found invariably 
in the sinusoids of the middle layer of the adrenal. In 17  cases, the leukocyte 
count in cardiac blood was 5,900-82,000/mm 3 (24,200  -4- 7,800/mm~). 
Rats  which  develop leukemia after a  set  of pulse-doses  of  7,8,12-TMBA 
are  somewhat  smaller  than  uninjected  controls  are  (Fig.  1).  There  was  no 
decline in body weight after pulse-dose one,  but a  retardation of growth was 
evident after subsequent injections. In early leukemia the rats appear healthy 
and active, but smaller than uninjected mates of the same sex. 
After each pulse-dose of 7,8,12-TMBA  there  was  a  characteristic pattern 
of decrease in the number of leukocytes (Fig.  2)  of the circulating blood. The 
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on days 3-5 with recovery to the initial preinjection value on days 7-10. We 
considered an interval of  14 days between the pulse-doses to be optimal for 
rapid  induction of leukemia with  the  smallest  number of early deaths  from 
toxicity. 
Characteristics  of Leukemia  in  Living Rats.--Two  novel signs  of leukemia 
were found in this study: (a) depression of pituitary function and (b) decrease 
of body temperature. These characteristics are useful in following the  course 
of leukemia. Both effects are nonspecific and they indicate far advanced leu- 
kemia. 
Decrease of pituitary function:  This  effect was  found out  by studying  the 
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FIG. 3.  Curves of body weight and rectal temperature of a rat which received the first of 
4 pulse-doses of 7,8,12-TMBA, 35 mg/kg, at age 50 days. Leukemia was detected by hepatic 
biopsy on day 72;  thereafter a  decline in body weight and temperature ensued and  estrus 
cycles ceased. Estrus is denoted by -~. 
estrus cycle. In our untreated control rats, first estrus occurred at age 46-68 
days  (52.3  4-  6.4  days).  The onset  of puberty was  delayed in juvenile rats 
injected with the leukemogenic hydrocarbons. A  group of 24 rats received 3 
pulse-doses of 7,8,12-TMBA, 35 mg/kg,  at biweekly intervals starting at age 
25 days; first estrus occurred at age 38-125 days (77.3  4-  28). 
In adult rats, four pulse-doses of 7,8,12-TMBA  caused little or no irregu- 
larity in the periodicity of the estrus cycle. When leukemia was  manifest the 
cycles stopped (Fig. 3). Estrus was absent for prolonged periods (15-38 days) 
before death occurred from leukemia.  The cause of diestrus in leukemia is not 
a  primary defect in ovary but  a  deficiency of gonadotrophin  production. In 
five rats with advanced leukemia, subcutaneous injections  of equine gonado- 
trophin were given for 3 days and estrus was restored. 
Decline  of body temperature:  The rectal temperature was  measured with  a 328  HYDROCARBON-INDUCED  LEUKEMIA 
thermocouple in  groups  of normal  control male  and  female rats,  age  60-81 
days. The findings were similar in males and females; the range of temperature 
was 37.6-38.4°C (38.0 4- 0.2°C). 
We observed a progressive decline in body temperature  (Fig. 3)  beginning 
some 24  wk before death from leukemia. 
Hepatic biopsy: Frequently small foci of proliferating cells are found in liver 
in untreated rats  in  our colony; many of these small  dense cells are normal 
erythroblasts but mitosis has not been seen in the clumps. 
In  leukemia  the  findings  are  quite  different.  In  the  stem-cell  leukemias 
clumps of large cells with an intensely basophilic nucleus and cytoplasm were 
found in the hepatic sinusoids. Mitoses were always present in these tiny foci 
of early leukemia (Fig. 4). In some cases the stem-cell leukemia was not asso- 
ciated with hemopoiesis (Fig. 5), but usually there was an associated prolifera- 
tion (Fig.  6)  of abnormal erythroblasts and normoblasts with multinudeated 
cells in abundance. 
In histologic sections of liver stained with hematoxylin-eosin the clumps of 
deep blue leukemic cells  form a  distinctive and striking contrast to the pink 
acidophilic cytoplasm of liver cells. 
It is  characteristic of the leukemic cells to progress,  often at  an  explosive 
rate,  until  the  sinusoidal  endothelium  of  the  liver  is  completely replaced, 
causing  hepatic  insufficiency. This violent advance of leukemia in successive 
biopsies  of the  liver differentiates the  malignant  process from benign extra- 
medullary hemopoiesis. 
In contrast to the diffuse hepatic type of erythroblastic leukemia which is 
sinusoidal  in site,  other types of leukemia induced by hydrocarbons located 
and proliferated in the periportal areas. 
DISCUSSION 
Novel findings in the present work are (a) the uniformity of the type of leu- 
kemia which was elicited, and (b) the rapidity with which the disease became 
manifest. 
One of the keys to the rapid induction of leukemia in high yield is the selec- 
tion of an appropriate experimental animal. Rats of L-E strain are especially 
suitable: for, there is a remarkably low incidence of spontaneous leukemia in 
untreated controls; the yield of leukemia in the injected animals  approaches 
100%;  the stock is hardy and unusually tolerant to the drastic effects of re- 
iterated doses  of the  strongly ]eukemogenic hydrocarbons, 7,12-DMBA  and 
7,8,12-TMBA. 
A  series of pulse-doses of the potent hydrocarbons is required to elicit leu- 
kemia in high yield, whereas a solitary dose is ineffective in this regard. Uematsu 
and  Huggins  (5)  found that  a  pulse-dose of 7,12-DMBA  or  7,8,12-TMBA 
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known (9) that 7,12-DMBA destroys only those cells which synthesize DNA; 
germinal cells which proliferate by meiosis (they do not synthesize DNA)  are 
unaffected by heavy doses of 7,12-DMBA.  The leukemia-producing effect of 
sets  of  pulse-doses  of  7,8,12-TMBA  is  associated  with  repeated  major  de- 
pressions of DNA synthesis in hemopoietic cells. 
A  stem-cell  erythroblastic leukemia  developed rapidly  in  nearly  all  L-E 
rats  which received a  series  of 4  or more pulse-doses  of 7,8,12-TMBA,  35 
mg/kg,  at  biweekly intervals.  It  is  a  simple  and  serviceable  method.  The 
diffuse hepatic leukemia has an unique characteristic--it grows rampantly in 
the  sinusoids  of the liver,  destroying their endothelial lining.  The explosive 
course  of erythroblastic leukemia  results  from the  exuberant growth  of the 
leukemic cells plus hepatic insufficiency. 
SI_YMM.ARY 
A  series of pulse-doses of 7,8,12-trimethylbenz(a)anthracene-induced leu- 
kemia rapidly and consistently in very high yield in rats of Long-Evans (L-E) 
strain. The predominant type was a diffuse hepatic leukemia of erythroblastic 
stem cells. 
Progressive hypothermia and a decline in pituitary function are newly recog- 
nized signs of advanced leukemia in rat. 
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FIG. 4.  Arrow points to a small clump of leukemia cells.  ×  250. 
FIG. 5.  Advanced hepatic stem-cell leukemia. X 200. 
FIG. 6.  Advanced hepatic stem-cell leukemia with erythroblastic differentiation-- 
advanced stage.  X 200. 
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